Scope and Purpose
There is a growing demand for academic education for oncologists and other scientists in the field to increase their clinical competence in the diagnosis and treatment of patients with lung cancer and thoracic malignancies. Cancer is predicted to be an increasingly important cause of morbidity and mortality in the next few decades, in all regions of the world.
The expected demographic changes in the next two decades mean that even if current global cancer rates remain unchanged, the estimated incidence of 12.7 million new cancer cases in 2008 will rise to 21.4 million by 2030, with nearly two thirds of all cancer diagnoses occurring in low- and middle-income countries (1).
According to GLOBOCAN 2012, lung cancer is the most commonly diagnosed cancer (1.8 million, 13.0% of the total) and most common cause of cancer death worldwide (1.6 million, 19.4% of the total) (2). Lung cancer incidence and mortality rates are still increasing in less developed parts of the world, also in some South Eastern European countries (3). In addition, there is a lack of access to equal, high-quality lung cancer care around Europe. Therefore, there is a growing, high demand for qualified and well-educated oncologists as well as other scientists dealing with lung cancer and with thoracic malignancies in general. The aim of the Certificate of Advanced Studies in Lung Cancer Programme is to reduce mortality from these cancers and to reduce disparities in survival rates between countries.
||Cancer incidence and mortality worldwide: Lyon, International Agency for Research on Cancer, 2011 (IARC CancerBase No.10).
||Latest world cancer statistics: International Agency for Research on Cancer, 2013
||Znaor A, van den Hurk C, Primic-Zakelj M, et al. Cancer incidence and mortality patterns in South Eastern Europe in last decade: Gaps persist compared with the rest of Europe. Eur J Cancer 2013; 49: 1683-91